Data updated: May 26, 2026
PHOSLYRA (calcium acetate)
Renal
Approved 2011-04-18
1
Indication
--
Phase 3 Trials
15
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2011-04-18
- Patent Cliff
- 2030
- Routes
- ORAL
- Dosage Forms
- SOLUTION
PHOSLYRA Approval History
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
6 FDA actions from 2011 to 2020
Aug 2014 SUPPL
Mfg · Manufacturing (CMC)
What PHOSLYRA Treats
1 FDA approvalsOriginally approved for its first indication in 2011 .
- Other (1)
📋
Clinical Trial Registry
3 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04299633 | AKB-6548-CI-0037 | Ph 1 | completed | Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat |
| NCT01277497 | 2902 | Ph 4 | terminated | Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 |
| NCT01135615 | GATAFGF23Sevelamer | Ph 4 | completed | Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PHOSLYRA FDA Label Details
View full patent landscape →
3 OB patents · 1 families ·
38 international docs across 18 countries
Pro Intelligence Preview
Deep insights for PHOSLYRA
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2030
- • 3 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Unlock Full Intelligence
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.